Ricardo Aguiar

Title: The Innovations of Ricardo Aguiar

Introduction

Ricardo Aguiar is a prominent inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of cancer research, particularly in the study of non-Hodgkin's lymphoma. With a total of four patents to his name, Aguiar's work focuses on the development of diagnostic methods and therapeutic targets for lymphoma-associated molecules.

Latest Patents

Aguiar's latest patents include groundbreaking inventions related to lymphoma-associated molecules. One of his patents provides isolated nucleic acid molecules, designated as BAL nucleic acid molecules, which are differentially expressed in non-Hodgkin's lymphoma. This invention encompasses antisense nucleic acid molecules, recombinant expression vectors containing BAL nucleic acid molecules, and host cells that have been modified with these vectors. Additionally, it includes non-human transgenic animals where a BAL gene has been introduced or disrupted. The patent also details isolated BAL proteins, fusion proteins, antigenic peptides, and anti-BAL antibodies, along with diagnostic methods utilizing these compositions.

Another significant patent by Aguiar focuses on BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules. Similar to his previous invention, this patent provides antisense nucleic acid molecules, recombinant expression vectors, and host cells modified with BBAP nucleic acid molecules. It also includes non-human transgenic animals with introduced or disrupted BBAP genes, as well as isolated BBAP proteins, fusion proteins, antigenic peptides, and anti-BBAP antibodies. Diagnostic methods using these compositions are also outlined in this patent.

Career Highlights

Ricardo Aguiar is affiliated with the Dana-Farber Cancer Institute Inc., where he conducts his research and development work. His innovative contributions have advanced the understanding of lymphoma and have the potential to improve diagnostic and therapeutic strategies in oncology.

Collaborations

Aguiar has collaborated with notable colleagues in his field, including Margaret A. Shipp and Liqun Gu. These collaborations have further enriched his research and have contributed to the advancement of cancer treatment methodologies.

Conclusion

Ricardo Aguiar's work in the field of cancer research, particularly regarding lymphoma-associated molecules, showcases his innovative spirit and dedication to improving patient outcomes. His patents reflect a commitment to advancing scientific knowledge and developing new diagnostic tools.